Open System Isolator Market Demands and Growth Predication 2017-2023

Posted by vinit sawant on March 31st, 2021

Market Highlights

The pharmaceutical industry is known as highly regulated industry and it is necessary to maintain the aseptic environment during the manufacturing process to meet the standards. Pharmaceutical isolators provide aseptic conditions and prevent the operator from being exposed to hazardous elements.  

The growing adoption of new technology in the manufacturing process, increasing use of open system isolators in research and development activities, and stringent regulatory policies are the major factors driving the growth of the global open system isolator market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market.

The global open system isolator market size is expected to grow during the forecast period (2018–2023) at a CAGR ~8.5%.

For instance, in March 2017, COMECER S.p.A. cf. p.iva. Has introduced The New Thecla Shielded Isolator in the market, this new isolator was introduced in the global market which will be available for use in academic as well as commercial manufacturing?

The high risk of contamination, costs associated to open system isolators and a shortage of technicians may hamper the growth of the market during the assessment period.

Regional Analysis

The market in the Americas is expected to dominate the global open system isolator market during the forecast period owing to the increasing pharmaceutical manufacturing, strict government and regulatory authorities and well-established healthcare sector in the region.

The European market is expected to be the second-largest due to the surge in research and development activities in the region along with growing concern about safety and efficacy of pharmaceutical products. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing production of generic pharmaceuticals in the region along with an increase in a number of manufacturing plants due to favorable conditions.

The market in the Middle East & Africa is likely to account for the smallest share of the global open system isolator market.